Kratos (KTOS) Form 4: Deanna Lund Sells 5,000 Shares via 10b5-1 Plan

Rhea-AI Filing Summary

Deanna H. Lund, EVP & CFO of Kratos Defense & Security Solutions (KTOS), reported sales of 5,000 shares on 08/19/2025 executed under a 10b5-1 trading plan adopted May 20, 2025. The sales were reported in four separate weighted-average-price lots: 2,200 shares at $64.29, 1,600 shares at $65.2431, 800 shares at $65.9425, and 400 shares at $67.35. After these transactions Ms. Lund beneficially owned 313,327 shares, which include shares held via the company ESPP and 401(k) plan.

The filing discloses the trades were pursuant to a preexisting trading plan, and the reporting attorney-in-fact signed the Form 4 on 08/21/2025. No derivative transactions or other amendments are shown.

Positive

• Transactions executed under a 10b5-1 plan, indicating pre-established trading parameters and an affirmative defense to insider trading claims
• Clear disclosure of weighted-average prices and price ranges for the multiple lots sold, improving transparency
• Reporting person retains a substantial holding after the sales (313,327 shares), signaling continued ownership exposure

Negative

• Insider sold 5,000 shares on 08/19/2025, which may be viewed negatively by some investors despite being under a plan
• Form 4 shows concentrated sales on a single date, which could be perceived as timing concentration even though covered by the plan

Insights

Financial Analyst

TL;DR: CFO sold 5,000 shares under a pre-established 10b5-1 plan; holding remains material at ~313k shares.

The filing documents routine insider sales rather than opportunistic trading: the 5,000-share disposition was executed under a 10b5-1 plan, reducing beneficial holdings to 313,327 shares. The weighted-average sale prices range roughly from $64 to $67.3, indicating execution across multiple price points on the same date. From an investor-impact perspective, the transaction supplies liquidity for the insider while the remaining stake remains sizeable; no exercise of options or debt-related transfers are reported.

Corporate Governance Expert

TL;DR: Disclosure adheres to Section 16 requirements and signals compliance via a documented 10b5-1 plan.

The Form 4 clearly states the trades were made pursuant to a 10b5-1 trading plan adopted May 20, 2025, and provides weighted-average price ranges for transparency. The signature by attorney-in-fact and the explanation footnotes comply with standard reporting practices. There is no indication of unusual or off-plan activity in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lund Deanna H

(Last) (First) (Middle)

10680 TREENA STREET, SUITE 600

(Street)

SAN DIEGO CA 92131

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. [ KTOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		S		2,200(1)	D	$64.29(2)	316,127(6)	D
Common Stock	08/19/2025		S		1,600(1)	D	$65.2431(3)	314,527(6)	D
Common Stock	08/19/2025		S		800(1)	D	$65.9425(4)	313,727(6)	D
Common Stock	08/19/2025		S		400(1)	D	$67.35(5)	313,327(6)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.74 to $64.72 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.75 to $65.73 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.80 to $66.36 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.04 to $67.96 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

6. Includes 16,626 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 19,746 shares held through Issuer's 401(k) Plan.

	Deanna H. Lund, by Eva Yee, Attorney-In-Fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did KTOS insider Deanna Lund report on Form 4?

The filing reports sales of 5,000 shares by Deanna H. Lund on 08/19/2025 under a 10b5-1 trading plan, with weighted-average prices between about $64.29 and $67.35.

How many shares does the KTOS reporting person own after the sales?

After the reported transactions the reporting person beneficially owned 313,327 shares, including shares from the ESPP and 401(k) plan.

Were the trades by the KTOS CFO part of a 10b5-1 plan?

Yes. The Form 4 states the transactions were effected pursuant to a 10b5-1 trading plan adopted May 20, 2025.

Are there any derivative securities reported for KTOS in this Form 4?

No. Table II (derivative securities) contains no reported transactions or holdings in this filing.

Who signed the Form 4 for the KTOS reporting person?

The Form 4 is signed by Deanna H. Lund, by Eva Yee, Attorney-In-Fact on 08/21/2025.